By Benjamin Horney ( November 19, 2015, 6:05 PM EST) -- Pfizer Inc. is closing in on a deal to buy Allergan PLC, the New York Times reported Thursday, and the transaction could see the pharmaceutical giant pay up to $150 billion for the Irish drugmaker. According to the report, a deal could value Allergan at up to $380 per share, and such a transaction would be the largest so far this year. The two companies confirmed in late October that they were in talks concerning a potential deal, though at that time they described it as "preliminary friendly discussions." Bringing together Allergan and Pfizer would create a pharmaceutical behemoth with a combined market capitalization of nearly $340 billion....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.